Multisystem Langerhans Cell Histiocytosis in Children: Current Treatment and Future Directions

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.13, Iss.2, 2011-04, pp. : 75-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug therapy for the treatment of Langerhans cell histiocytosis

By McClain Kenneth L

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2435-2441

Informa Healthcare

Access to resources Recommend Favorite

Medical management of langerhans cell histiocytosis from diagnosis to treatment

By Donadieu Jean Chalard François Jeziorski Eric

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1309-1322

Informa Healthcare

Access to resources Recommend Favorite

Clonal Status and Clinicopathological Features of Langerhans Cell Histiocytosis

By Gong L Zhang W-D Li Y-H Liu X-Y Yao L Han X-J Zhu S-J Lan M Zhang W

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1099-1105

Field House Publishing

Access to resources Recommend Favorite

Current and Future Treatment Directions in T2DM

Inpharma, Vol. 1, Iss. 1607, 2007-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Current and future directions in the treatment of squamous cell carcinoma of the head and neck: multidisciplinary symposium on head and neck cancer

By Haddad Robert

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 2, 2006-04 ,pp. : 333-336

Informa Healthcare

Access to resources Recommend Favorite